Iniciar sesión Regístrese gratis

Albireo Pharma Inc Quick ratio

¿Qué es el Quick ratio de Albireo Pharma Inc?

El Quick ratio de Albireo Pharma Inc es 6.23

¿Cuál es la definición de Quick ratio?



El ratio rápido es la relación de liquidez que mide la capacidad de una empresa para usar sus activos rápidos para cumplir con sus obligaciones a corto plazo de forma inmediata.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio de compañías en Sector Health Care en NASDAQ en comparadas con Albireo Pharma Inc

¿Qué hace Albireo Pharma Inc?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Empresas con quick ratio similar a Albireo Pharma Inc